Team:BGU Israel/Project/Aspiration Shift

From 2014.igem.org

(Difference between revisions)
Line 107: Line 107:
     </footer>
     </footer>
</html>
</html>
 +
{{Team:BGU_Israel/style.css}}
 +
{{Team:BGU_Israel/Menu}}
 +
<html>
 +
   
 +
      <section>
 +
      <div style="height:12px"> </div>
 +
    <div style="margin-bottom:10px"> <img src="https://static.igem.org/mediawiki/2014/9/99/BGU14Aspiration_Shift_Banner.png"  alt=""/></div>
 +
     
 +
     
 +
        <div class="col3" style="height: 200px;">
 +
        <h3 style="border-bottom:dashed;border-color:#000000">Background            <a href="#" onclick="goToByScroll('background'); return false;" class="right"></a></h3>
 +
        <br>
 +
        <b>The problem: </b>Abnormal aggregation of fatty acid in non-adipose tissues, particularly skeletal muscles and liver.
 +
<br>
 +
        <b>Goal: </b>Increase fatty acid oxidation, lipid transport and mitochondrial biogenesis processes.
 +
        </div>
 +
        <div class="col3" style="height:200px;">
 +
        <h3 style="border-bottom:dashed;border-color:#000000">Mechanism  <a href="#" onclick="goToByScroll('test'); return false;" class="right"></a></h3>
 +
        <br>
 +
        Activation of PPARγ by modest overexpression of PGC-1α
 +
 +
        </div>
 +
        <div class="col3" style="height:200px; margin-right:0px;">
 +
        <h3 style="border-bottom:dashed;border-color:#000000">Modeling </h3>
 +
        <br>
 +
 +
       
 +
 
 +
     
 +
        </div>
 +
       
 +
          <div class="clear"></div>
 +
          <div class="container_12 center">
 +
        <a href="#" onclick="goToByScroll('background'); return false;" class="down"></a>
 +
          </div>
 +
          <div id="background" style="height:100px"></div>
 +
      <div class="textCont" style="height: 320px;">
 +
      <h3 style="border-bottom:dashed;border-color:#000000">Background </h3>
 +
        <div class="col2">
 +
        <br>
 +
One of the most serious effects of unbalanced fat metabolism, is an abnormal aggregation of fatty acid in non-adipose tissues, particularly skeletal muscles and liver. This effect is strongly associated with insulin resistance and obesity. One of the key members which can reduce abnormal fat accumulation is peroxisome proliferator-activated receptor γ (PPARγ), a member of the nuclear hormone receptor family of ligand-activated transcription factors. This receptor increases the expression of genes important to fatty acid oxidation, lipid transport<div id="test"></div> and mitochondrial biogenesis processes (Aharoni-simon, Hann-obercyger, Pen, Madar, & Tirosh, 2011).
 +
 +
       
 +
 
 +
        </div>
 +
        <div class="col2">
 +
        <br>
 +
        In vivo induction of the PPARγ coactivator 1α (PGC-1α) shows increased insulin-sensitizing effects and a high level of oxidative capacity. However, overexpression of PGC-1α induced insulin resistance (Benton, Holloway, Han, & Yoshida, 2010).
 +
 +
        </div>
 +
        </div>
 +
       
 +
        <div class="textCont" style="height: 570px; margin-bottom: 12px;">
 +
      <h3 style="border-bottom:dashed;border-color:#000000">Mechanism </h3>
 +
        <div class="col2">
 +
        <br>
 +
          In order to prevent this phenomenon, we designed a self-regulating mechanism, which leads to modest overexpression of PGC-1α, shown in figure 1. We chose sterol regulatory elements (SRE) to promote the  expression of PGC-1α. When the cell is in an anabolic state, i.e. accumulating  fatty acids, a transcription factor called SREBP (Sterol Regulatory  Element-Binding, Proteins) is expressed (Shimomura, Bashmakov, &amp; Horton, 1999). As its name  suggests, the SREBP binds the sterol regulatory elements and induce the  expression of PGC-1α.  <br>
 +
          In order to limit  the expression of PGC-1α and  prevent supra-physiological overexpression, we add a PPARγ sensitive promoter which controls the  expression of a repressor which binds to an operator downstream the sterol  regulatory elements. This way, PGC-1α inhibits  its own expression and stays in a modest physiological concentration.
 +
         
 +
          <br>
 +
          <br>
 +
          <br>
 +
          <br>
 +
         
 +
        <p align="center" style="border: thin solid; border-radius: 8px; background: #5FA6B8; font-style: normal; font-weight: 700; font-size: 24px; font-family: Allan, 'Hoefler Text', 'Liberation Serif', Times, 'Times New Roman', serif;"> Click on the picture to check out the machanism <img src="https://static.igem.org/mediawiki/2014/d/dd/BGU14finger-point.gif" width="26px"/></p>
 +
        </div>
 +
       
 +
       
 +
        <div class="col2">
 +
       
 +
        <p align="center">
 +
        <img id="figure1" src="https://static.igem.org/mediawiki/2014/f/f2/BGU14PGC-1-1.png" onclick="change_pic()" width="400" style="border: thin solid; cursor: pointer;">
 +
        </p>
 +
        <p align="center" style="font-size:14px; font-weight:bold; line-height:normal">Figure 1 –  SREBP serves as a molecular indicator for fat accumulation in the cell and  induces the expression of PGC1-α by binding to the sterol regulatory elements  in our construct (SRE). PGC1-α then activates a negative feedback loop,  inhibiting its own expression. The result is a modest expression of PGC1-α in  the cell.</p>
 +
       
 +
        </div>
 +
        </div>
 +
        <div class="textCont" style="height: 380px; margin-bottom: 12px;">
 +
      <h3 style="border-bottom:dashed;border-color:#000000">References </h3>
 +
      <p>Aharoni-simon, M.,  Hann-obercyger, M., Pen, S., Madar, Z., &amp; Tirosh, O. (2011). Fatty liver is  associated with impaired activity of PPAR g -coactivator 1 a ( PGC1 a ) and  mitochondrial biogenesis in mice, <em>91</em>(July),1018–1028.  </p>
 +
      <p>doi:10.1038/labinvest.2011.55</p>
 +
      <p>Benton, C. R., Holloway, G. P., Han,  X., &amp; Yoshida, Y. (2010). Increased levels of peroxisome  proliferator-activated receptor gamma , coactivator 1 alpha ( PGC-1 α ) improve  lipid utilisation , insulin signalling and glucose transport in skeletal muscle  of lean and insulin-resistant obese Zucker rats, 2008–2019.</p>
 +
      <p> doi:10.1007/s00125-010-1773-1<br><br>
 +
        Shimomura, I., Bashmakov, Y., &amp;  Horton, J. D. (1999). Increased Levels of Nuclear SREBP-1c Associated with  Fatty Livers in Two Mouse Models of Diabetes Mellitus. <em>Journal of Biological  Chemistry</em>, <em>274</em>(42), 30028–30032. </p>
 +
      <p>doi:10.1074/jbc.274.42.30028</p>
 +
        </div>
 +
      </section>
 +
 +
    <!--==============================footer=================================-->
 +
    <footer>
 +
      <div class="container_12">
 +
            <div class="row">
 +
                <div class="grid_12">
 +
               
 +
                    <a href="#" class="f_logo">
 +
                    <img src="https://static.igem.org/mediawiki/2014/0/02/Igem-logo-BGU14doctor-hd.png" width="230" height="100"></a>
 +
                    <div class="footer_socials">
 +
                        <a href="#" class="fa fa-twitter"></a>
 +
                        <a href="#" class="fa fa-facebook"></a>
 +
                        <a href="#" class="fa fa-youtube-square"></a>
 +
                   
 +
                  </div>   
 +
                </div>
 +
            </div>
 +
        </div>
 +
        <div class="clear"></div>
 +
    </footer>
 +
</html>
 +
{{Team:BGU_Israel/Footer}}

Revision as of 06:34, 17 October 2014

Background


The problem: Abnormal aggregation of fatty acid in non-adipose tissues, particularly skeletal muscles and liver.
Goal: Increase fatty acid oxidation, lipid transport and mitochondrial biogenesis processes.

Mechanism


Activation of PPARγ by modest overexpression of PGC-1α

Modeling


Background


One of the most serious effects of unbalanced fat metabolism, is an abnormal aggregation of fatty acid in non-adipose tissues, particularly skeletal muscles and liver. This effect is strongly associated with insulin resistance and obesity. One of the key members which can reduce abnormal fat accumulation is peroxisome proliferator-activated receptor γ (PPARγ), a member of the nuclear hormone receptor family of ligand-activated transcription factors. This receptor increases the expression of genes important to fatty acid oxidation, lipid transport
and mitochondrial biogenesis processes (Aharoni-simon, Hann-obercyger, Pen, Madar, & Tirosh, 2011).

In vivo induction of the PPARγ coactivator 1α (PGC-1α) shows increased insulin-sensitizing effects and a high level of oxidative capacity. However, overexpression of PGC-1α induced insulin resistance (Benton, Holloway, Han, & Yoshida, 2010).

Mechanism


In order to prevent this phenomenon, we designed a self-regulating mechanism, which leads to modest overexpression of PGC-1α, shown in figure 1. We chose sterol regulatory elements (SRE) to promote the expression of PGC-1α. When the cell is in an anabolic state, i.e. accumulating fatty acids, a transcription factor called SREBP (Sterol Regulatory Element-Binding, Proteins) is expressed (Shimomura, Bashmakov, & Horton, 1999). As its name suggests, the SREBP binds the sterol regulatory elements and induce the expression of PGC-1α. 
In order to limit the expression of PGC-1α and prevent supra-physiological overexpression, we add a PPARγ sensitive promoter which controls the expression of a repressor which binds to an operator downstream the sterol regulatory elements. This way, PGC-1α inhibits its own expression and stays in a modest physiological concentration.



Click on the picture to check out the machanism

Figure 1 – SREBP serves as a molecular indicator for fat accumulation in the cell and induces the expression of PGC1-α by binding to the sterol regulatory elements in our construct (SRE). PGC1-α then activates a negative feedback loop, inhibiting its own expression. The result is a modest expression of PGC1-α in the cell.

References

Aharoni-simon, M., Hann-obercyger, M., Pen, S., Madar, Z., & Tirosh, O. (2011). Fatty liver is associated with impaired activity of PPAR g -coactivator 1 a ( PGC1 a ) and mitochondrial biogenesis in mice, 91(July),1018–1028.

doi:10.1038/labinvest.2011.55

Benton, C. R., Holloway, G. P., Han, X., & Yoshida, Y. (2010). Increased levels of peroxisome proliferator-activated receptor gamma , coactivator 1 alpha ( PGC-1 α ) improve lipid utilisation , insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats, 2008–2019.

doi:10.1007/s00125-010-1773-1

Shimomura, I., Bashmakov, Y., & Horton, J. D. (1999). Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus. Journal of Biological Chemistry, 274(42), 30028–30032.

doi:10.1074/jbc.274.42.30028

Background


The problem: Abnormal aggregation of fatty acid in non-adipose tissues, particularly skeletal muscles and liver.
Goal: Increase fatty acid oxidation, lipid transport and mitochondrial biogenesis processes.

Mechanism


Activation of PPARγ by modest overexpression of PGC-1α

Modeling


Background


One of the most serious effects of unbalanced fat metabolism, is an abnormal aggregation of fatty acid in non-adipose tissues, particularly skeletal muscles and liver. This effect is strongly associated with insulin resistance and obesity. One of the key members which can reduce abnormal fat accumulation is peroxisome proliferator-activated receptor γ (PPARγ), a member of the nuclear hormone receptor family of ligand-activated transcription factors. This receptor increases the expression of genes important to fatty acid oxidation, lipid transport
and mitochondrial biogenesis processes (Aharoni-simon, Hann-obercyger, Pen, Madar, & Tirosh, 2011).

In vivo induction of the PPARγ coactivator 1α (PGC-1α) shows increased insulin-sensitizing effects and a high level of oxidative capacity. However, overexpression of PGC-1α induced insulin resistance (Benton, Holloway, Han, & Yoshida, 2010).

Mechanism


In order to prevent this phenomenon, we designed a self-regulating mechanism, which leads to modest overexpression of PGC-1α, shown in figure 1. We chose sterol regulatory elements (SRE) to promote the expression of PGC-1α. When the cell is in an anabolic state, i.e. accumulating fatty acids, a transcription factor called SREBP (Sterol Regulatory Element-Binding, Proteins) is expressed (Shimomura, Bashmakov, & Horton, 1999). As its name suggests, the SREBP binds the sterol regulatory elements and induce the expression of PGC-1α. 
In order to limit the expression of PGC-1α and prevent supra-physiological overexpression, we add a PPARγ sensitive promoter which controls the expression of a repressor which binds to an operator downstream the sterol regulatory elements. This way, PGC-1α inhibits its own expression and stays in a modest physiological concentration.



Click on the picture to check out the machanism

Figure 1 – SREBP serves as a molecular indicator for fat accumulation in the cell and induces the expression of PGC1-α by binding to the sterol regulatory elements in our construct (SRE). PGC1-α then activates a negative feedback loop, inhibiting its own expression. The result is a modest expression of PGC1-α in the cell.

References

Aharoni-simon, M., Hann-obercyger, M., Pen, S., Madar, Z., & Tirosh, O. (2011). Fatty liver is associated with impaired activity of PPAR g -coactivator 1 a ( PGC1 a ) and mitochondrial biogenesis in mice, 91(July),1018–1028.

doi:10.1038/labinvest.2011.55

Benton, C. R., Holloway, G. P., Han, X., & Yoshida, Y. (2010). Increased levels of peroxisome proliferator-activated receptor gamma , coactivator 1 alpha ( PGC-1 α ) improve lipid utilisation , insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats, 2008–2019.

doi:10.1007/s00125-010-1773-1

Shimomura, I., Bashmakov, Y., & Horton, J. D. (1999). Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus. Journal of Biological Chemistry, 274(42), 30028–30032.

doi:10.1074/jbc.274.42.30028